Stem Point Capital LP Avidity Biosciences, Inc. Transaction History
Stem Point Capital LP
- $378 Billion
- Q1 2024
A detailed history of Stem Point Capital LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 75,000 shares of RNA stock, worth $3.19 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
75,000Holding current value
$3.19 Million% of portfolio
0.05%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RNA
# of Institutions
165Shares Held
71.6MCall Options Held
182KPut Options Held
55K-
Rtw Investments, LP New York, NY7.97MShares$339 Million3.26% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.43MShares$316 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.17MShares$262 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.83MShares$248 Million1.79% of portfolio
-
Cowen And Company, LLC5.63MShares$239 Million4.83% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.22B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...